DATA SHEET

This data sheet is provided for information only.
Please contact our Customer Service for further information.

PRODUCT NAME: Influenza B virus
CATALOGUE #: 8IN75-2

Source:
Allantoic fluid of 10 days old embryonated eggs, inoculated with influenza B virus, strain B/Tokio/53/99.

Purification:
Ultracentrifugation with 10 - 40 % sucrose gradient.

Presentation:
STE, 0.1 % sodium azide (NaN3) and 0.005 % thimerosal.

Inactivation:
Thimerosal and beta propiolactone treatment
This product has been treated in a manner consistent with methods of inactivation. Generally accepted good laboratory practices appropriate to microbiological/viral safe handling practices and techniques are required at work.

Analysis:
Purity > 90 %

Immunological activity:
Tested with anti-influenza B monoclonal antibodies (Cat. # 3IF18) in ELISA.

Application:
Serological studies of influenza B virus, immunogen for antibody production.

Storage:
- 20 ^oC

Material safety note:
Contains sodium azide (0.1 %) as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.

Related products:
Cat# 3BH9: Influenza B haemagglutinin, antibody 
Cat# 3BM17: Influenza B Matrix protein M1, antibody
Cat# 3IF18: Influenza B nucleoprotein, antibody
Cat# 8IN75: Influenza B Virus
Cat# 8IN75-3: Influenza B virus-3 
Cat# 8IN75-4: Influenza B virus-4  
Cat# 8IN75-5: Influenza B virus-5  
Cat# 8IN75-6: Influenza B virus-6  
Influenza and Other Acute Respiratory Diseases (ARDs) Newsletter

See other Infectious and veterinary reagents

References:
Search Influenza B virus-2 references from PubMed
See other Influenza References